Study,D1,D2,D3,D4,D5,D6,D7,Overall,Type,Intervention
Gokhale (2023),Serious,Low,Low,Low,Low,Moderate,Low,Moderate,Retrospective Cohort,Metformin
Lee (2019),Serious,Critical,Serious,Low,Moderate,Low,Low,Serious,Case Control,Metformin
Eton (2022),Serious,Moderate,Low,Low,Moderate,Low,Moderate,Moderate,Retrospective Cohort,Metformin
Stewart (2020),Serious,Serious,Low,Low,Moderate,Moderate,Low,Serious,Cross Sectional,Metformin
Jiang (2022),Critical,Critical,Critical,Moderate,Serious,Moderate,Moderate,Critical,Retrospective Cohort,Metformin
Brown (2019),Critical,Critical,Serious,Serious,Serious,Moderate,Moderate,Serious,Case Control,Metformin
Kaufmann (2023),Serious,Serious,Low,Low,Moderate,Moderate,Low,Serious,Case Control,Metformin
Khanna (2022),Serious,Serious,Low,Low,Moderate,Moderate,Low,Serious,Case Control,Metformin
Aggarwal (2024),Serious,Serious,Low,Low,Moderate,Moderate,Low,Serious,Case Control,Metformin
Starr (2022),Serious,Serious,Moderate,Low,Moderate,Moderate,Low,Serious,Case Control,Metformin
Chen (2019),Serious,Moderate,Moderate,Low,Low,Moderate,Low,Moderate,Case Control,Metformin
Blitzer (2021),Serious,Serious,Low,Low,Moderate,Moderate,Low,Serious,Case Control,Metformin
Tseng (2023),Moderate,Low,Moderate,Low,Low,Moderate,Low,Moderate,Retrospective Cohort,Metformin
Brilliant (2016),Critical,Serious,Moderate,Low,Serious,Moderate,Moderate,Serious,Cross Sectional,Levadopa
Figueroa (2020),Serious,Moderate,Low,Low,Low,Serious,Low,Serious,Phase 2 Clinical Trial,Levadopa
Hyman (2023),Serious,Serious,Moderate,Moderate,Critical,Moderate,Low,Serious,Case Control,Levadopa